149 related articles for article (PubMed ID: 17917082)
1. Tissue levels of adiponectin in breast cancer patients.
Karaduman M; Bilici A; Ozet A; Sengul A; Musabak U; Alomeroglu M
Med Oncol; 2007; 24(4):361-6. PubMed ID: 17917082
[TBL] [Abstract][Full Text] [Related]
2. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
4. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and breast cancer risk.
Mantzoros C; Petridou E; Dessypris N; Chavelas C; Dalamaga M; Alexe DM; Papadiamantis Y; Markopoulos C; Spanos E; Chrousos G; Trichopoulos D
J Clin Endocrinol Metab; 2004 Mar; 89(3):1102-7. PubMed ID: 15001594
[TBL] [Abstract][Full Text] [Related]
6. Serum adiponectin and leptin levels in Taiwanese breast cancer patients.
Chen DC; Chung YF; Yeh YT; Chaung HC; Kuo FC; Fu OY; Chen HY; Hou MF; Yuan SS
Cancer Lett; 2006 Jun; 237(1):109-14. PubMed ID: 16019138
[TBL] [Abstract][Full Text] [Related]
7. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.
Shahar S; Salleh RM; Ghazali AR; Koon PB; Mohamud WN
Asian Pac J Cancer Prev; 2010; 11(1):61-6. PubMed ID: 20593932
[TBL] [Abstract][Full Text] [Related]
8. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
9. Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer?
Sonmez B; Seker M; Bilici A; Yavuz Erkal F; Oven Ustaalioglu BB; Gumus M; Ozturk Guler D; Karaduman M; Gezen C; Eser M; Bildik N; Salepci T
J BUON; 2011; 16(2):227-32. PubMed ID: 21766490
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma].
Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937
[TBL] [Abstract][Full Text] [Related]
13. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
14. Tissue expression and serum levels of HER-2/neu in patients with breast cancer.
Krainer M; Brodowicz T; Zeillinger R; Wiltschke C; Scholten C; Seifert M; Kubista E; Zielinski CC
Oncology; 1997; 54(6):475-81. PubMed ID: 9394844
[TBL] [Abstract][Full Text] [Related]
15. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.
Shukla S; Singh BK; Pathania OP; Jain M
Indian J Med Res; 2016 May; 143(Supplement):S52-S58. PubMed ID: 27748278
[TBL] [Abstract][Full Text] [Related]
18. Tumor characteristics and metabolic quantification in carcinoma breast: An institutional experience.
Dubey IP; Jain A; Chauhan MS; Kumar R; Agarwal S; Kishore B; Vishnoi MG; Paliwal D; John AR; Kumar N; Sharma A; Pandit AG
Indian J Cancer; 2017; 54(1):333-339. PubMed ID: 29199717
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin concentrations and risk of incident breast cancer.
Tworoger SS; Eliassen AH; Kelesidis T; Colditz GA; Willett WC; Mantzoros CS; Hankinson SE
J Clin Endocrinol Metab; 2007 Apr; 92(4):1510-6. PubMed ID: 17213279
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
